OMEDtech

MDUFA III Guidance Documents Final Release

OMEDTech — Wed, 02 Jan 2013 22:19:02 +0000

FDA released three MDUFA III guidance documents on 12/31/2012. Happy New Year! The guidance documents discuss key provisions of MDUFA III. The guidances are on the eCopy program, Premarket Approval Applications and 510(k) files acceptance criteria. For a little light reading, check out this link.

MedVentures Conference

OMEDTech — Thu, 11 Oct 2012 15:26:57 +0000

OMEDtech attended the MedVentures Conference in Dallas, on October 10, 2012.

David Makanani at the OMEDtech booth

MedVentures is an early-stage investment and education conference focusing on the rapidly growing medical technology sector. The medical technology sector includes medical devices and instruments, diagnostic equipment, medical therapeutic devices, medical monitoring equipment and other health-related products and services.

New Release! BS EN ISO 14971:2012

OMEDTech — Thu, 06 Sep 2012 16:34:08 +0000

BS EN ISO 14971:2012, Medical Device Risk Management, was released July 6, 2012. This revision changes only the EN version and not the ISO version. With regards to the EN version, more informative references have been added between the standard and the medical device directive (MDD 93/42/EEC). Some of these changes may present a challenge to medical device manufacturer’s that have CE marked products that they are marketing in Europe. OMEDtech offers Risk Management consulting services to help companies navigate the requirements of the standards.

MDR, Complaints, Recalls, Corrections and Removals

OMEDTech — Thu, 06 Sep 2012 15:07:53 +0000

Missed the FDA’s educational forum on Medical Device Reporting (MDR), Complaints, Recalls, Corrections and Removals? Check out this link for the handouts.

New Mandatory Requirement for ISO Certifiers

OMEDTech — Thu, 23 Aug 2012 16:43:20 +0000

A new Mandatory Document (MD9) has been published. All ISO certification bodies issuing ISO 13485 certificates (under an IAF accreditation body) are required to apply MD9 to medical device manufacturer assessments starting July 2012. One requirement that may affect Manufacturer’s seeking ISO certification is an increase in the total duration of ISO 13485 audits. The details of this may be found in MD9 Annex D.

Medical Device Design Control

OMEDTech — Tue, 14 Aug 2012 16:08:35 +0000

Automation of the Design Control process can help product development teams navigate mandatory FDA regulations for medical device design controls. By making this process easier and more efficient, innovative medical devices can get to market quicker thereby having a greater impact of people’s lives. Tietronix Software has developed a Medical Device Accelerator (MDA), a web based system that includes design control, document control, CAPA and MDR reporting features. The MDA can benefit start-up companies by offering a “cafeteria” style plan, where a company can choose only the processes required at their stage of development. Click on MDA to read the entire article in Medical Design Briefs.

Senate Passes Unprecedented Medical Device User Fee Act

OMEDTech — Mon, 23 Jul 2012 16:24:25 +0000

The senate passed new legislation, June 26, that reauthorizes the latest version of the user fee bill. The bill introduces performance goals for the FDA. The bill nearly doubles the fees paid by medical device manufacturers. Medical device Manufacturers are required to pay fees for certain services that include 510(k) and PMA submissions and establishment registration. The bill seems to be supported by most of the industry as a positive step for shorter review times and encouraging product innovation. Read the entire article here.

Exciting New Medical Device Treats Brain Cancer

OMEDTech — Wed, 27 Jun 2012 20:50:52 +0000

Novocure, a solid tumor treatment company, has seen promising results in a phase III trial with it’s NovoTTF therapy. NovoTTF therapy is indicated for chemotherapy free treatment of recurrent glioblastoma multiforme (GBM) brain tumors. The results of the trial were comparable to active chemotherapy in extending overall survival, with minimal side effects and far better quality of life. Read the news release to find out more about NovoTTF-100 that is currently approved for marketing in the US and Europe.

Children’s reaction to Cochlear implant

OMEDTech — Thu, 07 Jun 2012 22:01:34 +0000

When you’re frustrated with the regulatory process of getting a new medical device to market. This article is a great reminder of why it’s worth the effort. Watch what happens when children, who have received a cochlear implant, react to hearing for the first time.

Early registration ends June 1!

OMEDTech — Thu, 24 May 2012 15:40:52 +0000

Early registration ends June 1

FMDIC’s early registration for the upcoming educational forum with FDA ends June 1. Registration fees go up thereafter. Registration info:

http://fmdic.org/events-training/mdr-complaints-recalls/